Page 105 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 105

Epidemiology of Primary Systemic Vasculitis  81

[50] Terao, C., Yoshifuji, H., Kimura, A., et al. Two susceptibility loci to Takayasu arteritis
       reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population. Am.
       J. Hum. Genet. 2013; 93:289-297.

[51] Saruhan-Direskeneli, G., Hughes, T., et al. Identification of multiple genetic
       susceptibility loci in Takayasu arteritis. Am. J. Hum. Genet. 2013; 93:298-305.

[52] Watts, R., Al-Taiar, A., Mooney, J., et al. The epidemiology of Takayasu arteritis in the
       UK. Rheumatology 2009; 48:1008-1011.

[53] Mohammad, A., Mandl, T. Takayasu?s arteritis in southern Sweden. Presse Med. 2013;
       42:719.

[54] Waern, A. U., Andersson, P., Hemmingsson, A. Takayasu?s arteritis: a hospital-region
       based study on occurrence, treatment and prognosis. Angiology 1983 34:311-320.

[55] Reinhold-Keller, E., Herlyn, K., Wagner-Bastmeyer, R., et al. Stable incidence of
       primary systemic vasculitides over five years: results from the German vasculitis
       register. Arthritis Rheum. 2005; 53:93-99.

[56] Dreyer, L., Faurschou, M., Baslund, B. A population-based study of Takayasu?s
       arteritis in eastern Denmark. Clin. Exp. Rheumatol. 2011; 29(Suppl. 64):S40-S42.

[57] Lightfoot, R. W. Jr, Michel, B. A., Bloch, D. A., et al. The American College of
       Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis
       Rheum. 1990; 33:1088-1093.

[58] Jennette, J. C., Falk, R. J., Bacon, P. A., et al. International Chapel Hill Consensus
       Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013; 65:1-11.

[59] Guillevin, L., Lhote, F. Polyarteritis nodosa and microscopic polyangiitis. Clin. Exp.
       Immunol. 1995; 101(Suppl. 1):22-23.

[60] Mahr, A., Guillevin, L., Poissonnet, M., et al. Prevalences of polyarteritis nodosa,
       microscopic polyangiitis, Wegener?s granulomatosis, and Churg-Strauss syndrome in a
       French urban multiethnic population in 2000:A capture –recapture estimate. Arthritis
       Rheum. 2004; 51:92-99.

[61] Ozen, S., Bakkaloglu, A., Dusunsel, R., et al. Childhood vasculitides in Turkey: a
       nationwide survey. Clin. Rheumatol. 2007; 26:196-200.

[62] Ozen, S., Ruperto, N., Dillon, M. J., et al. EULAR/PReS endorsed consensus criteria*
       for the classification of childhood vasculitides. Ann. Rheum. Dis. 2006; 65:936-941.

[63] McMahon, B. J., Heyward, W. L., Templin, D. W., et al. Hepatitis B-associated
       polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-
       term follow-up. Hepatology 1989; 9:97-101.

[64] Mohammad, A. J., Jacobsson, L. T. H., Westman, K. W. A., et al. Incidence and
       survival rates in Wegener?s granulomatosis, microscopic polyangiitis, Churg-Strauss
       syndrome and polyarteritis nodosa. Rheumatology 2009; 48:1560-1565.

[65] Watts, R. A., Gonzalez-Gay, M. A., Lane, S. E., et al. Geoepidemiology of systemic
       vasculitis: comparison of the incidence in two regions of Europe. Ann. Rheum. Dis.
       2001; 60:170-172.

[66] Omerod, A. S., Cook, M. C. Epidemiology of primary systemic vasculitis in the
       Australian Capital Territory and south-eastern New South Wales. Intern. Med. J. 2008;
       38: 816-823.

[67] Shulman, S. T., Rowley, A. H. Advances in Kawasaki disease. Eur. J. Pediatr. 2004;
       63: 285-291.

Complimentary Contributor Copy
   100   101   102   103   104   105   106   107   108   109   110